Gene Therapy in Action: CTLA4 Haploinsufficiency
Author: Caitlyn Hauke, PhD, RBP, CBSP (ABSA) Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This…
Gene Therapy in Action: Fabry Disease
Author: Caitlyn Hauke, Ph.D. Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the…
Gene Therapy In Action: Amyotrophic Lateral Sclerosis (ALS)
Authors: Garry Coulson, Ph.D. and Caitlyn Hauke, Ph.D. Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers….
![Gene Therapy in Action: Hunter Syndrome (Mucopolysaccharidosis Type II [MPSII])](https://sabaiglobal.com/wp-content/uploads/2024/09/sab-wp2-768x508.png)
Gene Therapy in Action: Hunter Syndrome (Mucopolysaccharidosis Type II [MPSII])
Author: Caitlyn Hauke, Ph.D. Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the…
Gene Therapy in Action: Thalassemia
Author: Caitlyn Hauke, PhD, RBP, CBSP (ABSA) Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series…
Swift, Responsive Site Support Drives Study Success
A client needed to open 50 U.S. sites for a viral vector cancer vaccine study. Finding sites with the right expertise and facilities was going…
Sabai Global Unifies Services, Streamlining Access to Its Comprehensive IRB and IBC Solutions
Sabai is proud to announce the consolidation of its subsidiary service lines—Castle IRB, CBS IBC and Shield Consulting—under one unified brand: Sabai Global. Now, all…
